Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Synthesis of Prostate Specific Membrane Antigen Targeting Dendrimers to Improve Positron Emission Tomography Imaging of Prostate Cancer

FY 2023-24

Summary
Molecular imaging, including positron emission tomography (PET) is a very useful tool for diagnosis of malignancies. PET uses probes which travel to biological structures to help diagnose pathologies. However, some of the most common probes used for PET imaging are not effective molecular probes for the imaging of prostate cancer. As a result, there is a need to develop new imaging probes for PET imaging of this malignancy, especially as it is the most common non-cutaneous type of cancer in men. One notable molecular marker on prostate cancer is prostate specific membrane antigen (PSMA). This membrane bound protein is highly expressed on cancerous prostate cells and molecular probes can be used to target it. We aim to develop dendrimers, which are highly-branched, nano-sized molecules, that are designed to target prostate cancer specifically. These dendrimers will be designed with PSMA targeting end branches to specifically bind to PSMA and will be radiolabeled with iodine-125 such that biodistribution assays can be performed. The distribution of these molecules will be studied and changes to the structure of the molecule can be made to improve characteristics of the probe. We hypothesize that by synthesizing dendrimers, which have hypervalent binding properties, with end branches designed to target PSMA, we will have created a molecular imaging probe that binds more specifically to prostate cancer cells. These dendrimers should be a marked improvement in PET imaging for malignant prostate cancer. This preliminary research will further guide research into the development of a multifunctional probe that can bind to any targeting vector in the body. Overall, this will improve diagnosis and radiotherapy applications for a broad range of malignancies.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506350
Name
Shivji Ariana
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Synthesis of Prostate Specific Membrane Antigen Targeting Dendrimers to Improve Positron Emission Tomography Imaging of Prostate Cancer
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Dendrimers; Diagnostic Imaging; Molecular Imaging; Multivalent Imaging Probe; Nuclear Imaging; Positron Emission Tomography; Prostate Cancer; Prostate Specific Membrane Antigen; Radiochemistry
Abstract
Molecular imaging, including positron emission tomography (PET) is a very useful tool for diagnosis of malignancies. PET uses probes which travel to biological structures to help diagnose pathologies. However, some of the most common probes used for PET imaging are not effective molecular probes for the imaging of prostate cancer. As a result, there is a need to develop new imaging probes for PET imaging of this malignancy, especially as it is the most common non-cutaneous type of cancer in men. One notable molecular marker on prostate cancer is prostate specific membrane antigen (PSMA). This membrane bound protein is highly expressed on cancerous prostate cells and molecular probes can be used to target it. We aim to develop dendrimers, which are highly-branched, nano-sized molecules, that are designed to target prostate cancer specifically. These dendrimers will be designed with PSMA targeting end branches to specifically bind to PSMA and will be radiolabeled with iodine-125 such that biodistribution assays can be performed. The distribution of these molecules will be studied and changes to the structure of the molecule can be made to improve characteristics of the probe. We hypothesize that by synthesizing dendrimers, which have hypervalent binding properties, with end branches designed to target PSMA, we will have created a molecular imaging probe that binds more specifically to prostate cancer cells. These dendrimers should be a marked improvement in PET imaging for malignant prostate cancer. This preliminary research will further guide research into the development of a multifunctional probe that can bind to any targeting vector in the body. Overall, this will improve diagnosis and radiotherapy applications for a broad range of malignancies.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shivji, Ariana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~